Article ID Journal Published Year Pages File Type
8348888 Peptides 2013 8 Pages PDF
Abstract
► We conducted a RCT to find an efficient octreotide regimen to prevent or treat SAP. ► No significant difference was between control and low-dose octreotide in efficacy. ► Compared to low-dose, high-dose octreotide efficiently reduce and attenuate SAP. ► Superior effect of high-dose was due to return of plasma SST to normal level. ► High-dose was also better in decreasing plasma level of IL-6 and TNF-α.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Biochemistry
Authors
, , , , , , , ,